Urosystem is dedicated to revolutionizing the treatment of lower urinary tract diseases, with a particular focus on interstitial cystitis/bladder pain syndrome (IC/BPS). With over 5 million people suffering from IC/BPS in the USA alone, and an estimated 100 million globally, Urosystem aims to address the lack of diagnosis and provide effective solutions. Their portfolio includes a range of medical devices, medications, and diagnostic methods specifically designed for IC/BPS. Importantly, many of these elements can also be used in the treatment of other lower urinary tract conditions such as recurring urinary tract infections and chemotherapy cystitis.

Located in Hungary, Urosystem has built a team of experts, led by globally renowned urologist Sándor Lovász and leading pharmacist Peter Birinyi, to develop and commercialize their inventions. The company has obtained a D&B Failure Score AAA certification, highlighting its financial stability and low risk for business relationships.

Additionally, Urosystem collaborates with partners such as IBSA and Tyro Medical, combining their expertise to expand their reach and effectively communicate the unique benefits of their products to medical professionals and patients worldwide.

For those seeking painless and complication-free treatment, Urosystem offers their first commercially available product, the UroDapter. This syringe adapter replaces the catheter in bladder instillation, ensuring a more comfortable experience.

Contact Urosystem for more information, and take the first step towards improving the quality of life for millions of individuals suffering from lower urinary tract conditions.